Globe Life Inc. (GL)
NYSE: GL
· Real-Time Price · USD
144.29
1.26 (0.88%)
At close: Sep 26, 2025, 1:11 PM
Globe Life Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Segment Revenue | 378.1M | 369.79M | 709.95M | 353.95M | 351.64M | 341.02M | 335.86M | 331.24M | 329.19M | 322.49M | 323.93M | 319.29M | 319.19M | 317M | 312.77M | 299.14M | 295.59M | 294.17M | 290.22M | 287.8M | 282.88M | 280.2M | 275.21M | 269.17M | 266.28M | 266.68M | 256.9M | 255.2M | 251.44M | 251.8M | 245.82M | 242.99M | 242.78M | 244.79M | 237.73M | 236.99M | 237.25M | 235.7M | 235.3M | 229.14M | 232.41M | 228.67M | 224.68M | 210.22M | 215.1M | 219.44M | 288.13M | 875.7M | 291.31M | 298.25M | 286.96M | 251.15M | 255.02M | 254.66M | 227.69M |
| Health Segment Revenue Growth | +2.25% | -47.91% | +100.58% | +0.66% | +3.12% | +1.54% | +1.40% | +0.62% | +2.08% | -0.44% | +1.45% | +0.03% | +0.69% | +1.35% | +4.56% | +1.20% | +0.48% | +1.36% | +0.84% | +1.74% | +0.95% | +1.81% | +2.25% | +1.08% | -0.15% | +3.81% | +0.67% | +1.50% | -0.14% | +2.43% | +1.16% | +0.09% | -0.82% | +2.97% | +0.31% | -0.11% | +0.66% | +0.17% | +2.69% | -1.41% | +1.63% | +1.78% | +6.88% | -2.27% | -1.98% | -23.84% | -67.10% | +200.60% | -2.32% | +3.93% | +14.26% | -1.52% | +0.14% | +11.85% | n/a |
| Life Segment Revenue | 839.54M | 829.86M | 1.64B | 818.64M | 815.48M | 804.26M | 794.82M | 788.1M | 781.73M | 772.6M | 753.65M | 755.12M | 759.92M | 754.6M | 733M | 728.92M | 728.17M | 708.12M | 678.33M | 674.02M | 670.82M | 649.63M | 631.47M | 630.82M | 631.2M | 624.29M | 600.17M | 605.55M | 602.53M | 598.3M | 580.65M | 576.22M | 573.84M | 575.84M | 550.18M | 546.41M | 548.59M | 544.15M | 520.76M | 518.93M | 520.04M | 513.34M | 493.57M | 491.72M | 491.95M | 489.06M | 468.47M | 1.42B | 475.11M | 470.81M | 452M | 453.7M | 450.95M | 451.88M | 432.09M |
| Life Segment Revenue Growth | +1.17% | -49.35% | +100.14% | +0.39% | +1.39% | +1.19% | +0.85% | +0.81% | +1.18% | +2.51% | -0.19% | -0.63% | +0.71% | +2.95% | +0.56% | +0.10% | +2.83% | +4.39% | +0.64% | +0.48% | +3.26% | +2.88% | +0.10% | -0.06% | +1.11% | +4.02% | -0.89% | +0.50% | +0.71% | +3.04% | +0.77% | +0.42% | -0.35% | +4.66% | +0.69% | -0.40% | +0.82% | +4.49% | +0.35% | -0.21% | +1.30% | +4.01% | +0.37% | -0.05% | +0.59% | +4.39% | -66.94% | +198.22% | +0.91% | +4.16% | -0.38% | +0.61% | -0.21% | +4.58% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 105.7M | 105.7M | 97.12M | n/a | 10.09M | 89.68M | 27.2M | 7.57M | 7.49M | 81.59M | 18.45M | 9.12M | 8.45M | 81.6M | 15.97M | 7.78M | 8.36M | 74.06M | 19.04M | 72.39M | 70.2M | 72.98M | 78.41M | 74.58M | 79.04M | 73M | 70M | 74M | 69M | 67M | 69M | 63M | 62M | 62M | 59M | 58M | 58M | 55.4M | 50.15M | 57.78M | 56.98M | 54.44M |
| Selling, General, and Administrative Revenue Growth | 0.00% | +8.83% | n/a | -100.00% | -88.75% | +229.65% | +259.51% | +1.08% | -90.82% | +342.27% | +102.27% | +7.95% | -89.65% | +410.83% | +105.43% | -7.03% | -88.71% | +289.05% | -73.70% | +3.12% | -3.81% | -6.93% | +5.15% | -5.65% | +8.28% | +4.29% | -5.41% | +7.25% | +2.99% | -2.90% | +9.52% | +1.61% | 0.00% | +5.08% | +1.72% | 0.00% | +4.69% | +10.48% | -13.21% | +1.41% | +4.66% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |